EICHOR
● Recruiting
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Condition: Atopic Dermatitis · Sponsor: Organon and Co
About this study
The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 23 months (inclusive) with atopic dermatitis.
This description comes directly from the study's public registry record.
Talk to the study team
Clinical Lead Late-Stage Clinical Development · 551-430-6000 · studysites@organon.com
Always discuss trial participation with your own doctor first.
Locations (46)
| AllerVie Clinical Research | Birmingham, Alabama, United States | Recruiting |
| Dermatology Trial Associates | Bryant, Arkansas, United States | Recruiting |
| Dermatology Research Associates | Los Angeles, California, United States | Recruiting |
| Integrative Skin Science and Research | Sacramento, California, United States | Recruiting |
| Allergy and Asthma Medical Group and Research Center | San Diego, California, United States | Recruiting |
| Clinical Trials Research Institute | Thousand Oaks, California, United States | Recruiting |
| Clarity Dermatology | Castle Rock, Colorado, United States | Recruiting |
| Skin Care Research, LLC. | Boca Raton, Florida, United States | Recruiting |
| APEX Clinical Trials | Jacksonville, Florida, United States | Recruiting |
| TruDerm Research | Wellington, Florida, United States | Recruiting |
| Cleaver Medical Group Dermatology, Inc | Cumming, Georgia, United States | Recruiting |
| Ada West Research | Meridian, Idaho, United States | Recruiting |
+ 34 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07265479